Except for IDH1-132, which is well-known in LGG and GBM [11], no other hotspot demonstrated significance in more than one cancer type, indicating that hotspots associated with survival in the “vs. All” test are specific to each cancer type. The gene discussed is IDH1; the disease is cancer.